Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy.
作者信息
Sethi Amit, Miao Jing, Willrich Maria Alice V, Frinack Jody L, Cattran Daniel C, Fervenza Fernando C
机构信息
University of Minnesota, Minneapolis, Minnesota.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
出版信息
Clin J Am Soc Nephrol. 2021 Jun;16(6):939-941. doi: 10.2215/CJN.16631020. Epub 2021 Apr 15.
Abstract
摘要
相似文献
1
Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy.抗补体H因子抗体在膜性肾病患者中的意义有限。
Clin J Am Soc Nephrol. 2021 Jun;16(6):939-941. doi: 10.2215/CJN.16631020. Epub 2021 Apr 15.
2
Factor H Autoantibodies and Membranous Nephropathy.补体因子H自身抗体与膜性肾病
N Engl J Med. 2018 Dec 20;379(25):2479-2481. doi: 10.1056/NEJMc1805857.
3
Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.特发性膜性肾病和非典型膜性肾病患者血清甘露糖结合凝集素、抗磷脂酶 A2 受体抗体与肾脏结局的相关性：一项单中心回顾性队列研究。
Ren Fail. 2022 Dec;44(1):428-433. doi: 10.1080/0886022X.2022.2048016.
4
Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.根据抗M型磷脂酶A2受体抗体的存在情况，特发性膜性肾病的临床特征、病程及预后
Nefrologia. 2015;35(5):479-86. doi: 10.1016/j.nefro.2015.05.026. Epub 2015 Jul 7.
5
Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.中国膜性肾病患者中的抗磷脂酶A2受体抗体
Med Sci Monit. 2016 May 15;22:1630-6. doi: 10.12659/msm.896090.
6
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.肾小球中 M 型磷脂酶 A2 受体的表达增强与原发性膜性肾病患者血清受体抗体相关。
Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.
7
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.神经表皮生长因子样 1 蛋白（NELL-1）相关膜性肾病。
Kidney Int. 2020 Jan;97(1):163-174. doi: 10.1016/j.kint.2019.09.014. Epub 2019 Oct 7.
8
Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods.抗磷脂酶A2受体相关膜性肾病：一篇重点关注诊断检测方法的综述
Clin Nephrol. 2015 Jul;84(1):1-9. doi: 10.5414/CN108602.
9
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.膜性肾病中的PLA2R自身抗体和PLA2R肾小球沉积物
N Engl J Med. 2011 Feb 17;364(7):689-90. doi: 10.1056/NEJMc1011678.
10
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.磷脂酶 A2 受体自身抗体与原发性膜性肾病患者的临床结局。
J Am Soc Nephrol. 2014 Jun;25(6):1357-66. doi: 10.1681/ASN.2013040430. Epub 2014 Mar 7.
引用本文的文献
1
A review of progress on complement and primary membranous nephropathy.补体与原发性膜性肾病研究进展述评。
Medicine (Baltimore). 2024 Jul 19;103(29):e38990. doi: 10.1097/MD.0000000000038990.
2
Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment.膜性肾病：更清晰的病理和机制为治疗提供了潜在策略。
Front Immunol. 2022 Nov 2;13:1036249. doi: 10.3389/fimmu.2022.1036249. eCollection 2022.
3
Kidney diseases.肾脏疾病。
Immunol Rev. 2023 Jan;313(1):239-261. doi: 10.1111/imr.13167. Epub 2022 Nov 12.
4
The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets.补体系统在原发性膜性肾病中的作用：新治疗靶点时代的叙述性综述。
Front Immunol. 2022 Oct 24;13:1009864. doi: 10.3389/fimmu.2022.1009864. eCollection 2022.
5
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.肾脏疾病与补体的作用：将补体与免疫效应途径和治疗联系起来。
Adv Immunol. 2021;152:1-81. doi: 10.1016/bs.ai.2021.09.001. Epub 2021 Nov 19.
Zotero 插件